Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients

Objective: To identify risk factors for Lymph Node Metastasis (LNM) in pT3-4 Laryngeal Squamous Cell Carcinoma (LSCC) patients with negative margins, and develop a nomogram to predict LNM risk. Methods: 872 patients were divided into training (2010–2014) and validation (2015–2016) cohorts. Univariat...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Brazilian Journal of Otorhinolaryngology
المؤلفون الرئيسيون: Changding He, Yu Heng, Xiaoke Zhu, Jian Zhou, Lei Tao
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Elsevier 2025-03-01
الموضوعات:
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S1808869424001502
_version_ 1850307503627173888
author Changding He
Yu Heng
Xiaoke Zhu
Jian Zhou
Lei Tao
author_facet Changding He
Yu Heng
Xiaoke Zhu
Jian Zhou
Lei Tao
author_sort Changding He
collection DOAJ
container_title Brazilian Journal of Otorhinolaryngology
description Objective: To identify risk factors for Lymph Node Metastasis (LNM) in pT3-4 Laryngeal Squamous Cell Carcinoma (LSCC) patients with negative margins, and develop a nomogram to predict LNM risk. Methods: 872 patients were divided into training (2010–2014) and validation (2015–2016) cohorts. Univariate and multivariate analyses identified LNM risk factors. A nomogram incorporating significant factors was developed in the training cohort. Results: Smoking history, maximal tumor diameter ≥3.0 cm, depth of tumor invasion >1.0 cm, and supraglottic tumor location were significantly associated with LNM on multivariate analysis. A predictive nomogram incorporating these factors showed good discrimination (C-index > 0.7) in both cohorts. Patients were stratified into low, moderate and high-risk subgroups based on total risk scores. Conclusions: A LNM risk prediction model and risk grouping system was established, which may aid treatment selection for pT3-4 LSCC patients. The model and algorithm could help optimize neck management for this high-risk patient population. Level of evidence: 2.
format Article
id doaj-art-ea0d7f87929541caa0bbe8ea3eb962ce
institution Directory of Open Access Journals
issn 1808-8694
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
spelling doaj-art-ea0d7f87929541caa0bbe8ea3eb962ce2025-08-19T23:28:41ZengElsevierBrazilian Journal of Otorhinolaryngology1808-86942025-03-0191210153510.1016/j.bjorl.2024.101535Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patientsChangding He0Yu Heng1Xiaoke Zhu2Jian Zhou3Lei Tao4Fudan University, Department of Otorhinolaryngology, Eye and ENT Hospital, Shanghai, ChinaFudan University, Department of Otorhinolaryngology, Eye and ENT Hospital, Shanghai, ChinaFudan University, Department of Otorhinolaryngology, Eye and ENT Hospital, Shanghai, ChinaFudan University, Department of Otorhinolaryngology, Eye and ENT Hospital, Shanghai, ChinaCorresponding author.; Fudan University, Department of Otorhinolaryngology, Eye and ENT Hospital, Shanghai, ChinaObjective: To identify risk factors for Lymph Node Metastasis (LNM) in pT3-4 Laryngeal Squamous Cell Carcinoma (LSCC) patients with negative margins, and develop a nomogram to predict LNM risk. Methods: 872 patients were divided into training (2010–2014) and validation (2015–2016) cohorts. Univariate and multivariate analyses identified LNM risk factors. A nomogram incorporating significant factors was developed in the training cohort. Results: Smoking history, maximal tumor diameter ≥3.0 cm, depth of tumor invasion >1.0 cm, and supraglottic tumor location were significantly associated with LNM on multivariate analysis. A predictive nomogram incorporating these factors showed good discrimination (C-index > 0.7) in both cohorts. Patients were stratified into low, moderate and high-risk subgroups based on total risk scores. Conclusions: A LNM risk prediction model and risk grouping system was established, which may aid treatment selection for pT3-4 LSCC patients. The model and algorithm could help optimize neck management for this high-risk patient population. Level of evidence: 2.http://www.sciencedirect.com/science/article/pii/S1808869424001502Laryngeal squamous cell carcinomaLymph node metastasisRisk stratification
spellingShingle Changding He
Yu Heng
Xiaoke Zhu
Jian Zhou
Lei Tao
Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
Laryngeal squamous cell carcinoma
Lymph node metastasis
Risk stratification
title Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
title_full Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
title_fullStr Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
title_full_unstemmed Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
title_short Development and internal validation of risk stratification tool for lymph node metastasis in pT3-4 laryngeal squamous cell carcinoma patients
title_sort development and internal validation of risk stratification tool for lymph node metastasis in pt3 4 laryngeal squamous cell carcinoma patients
topic Laryngeal squamous cell carcinoma
Lymph node metastasis
Risk stratification
url http://www.sciencedirect.com/science/article/pii/S1808869424001502
work_keys_str_mv AT changdinghe developmentandinternalvalidationofriskstratificationtoolforlymphnodemetastasisinpt34laryngealsquamouscellcarcinomapatients
AT yuheng developmentandinternalvalidationofriskstratificationtoolforlymphnodemetastasisinpt34laryngealsquamouscellcarcinomapatients
AT xiaokezhu developmentandinternalvalidationofriskstratificationtoolforlymphnodemetastasisinpt34laryngealsquamouscellcarcinomapatients
AT jianzhou developmentandinternalvalidationofriskstratificationtoolforlymphnodemetastasisinpt34laryngealsquamouscellcarcinomapatients
AT leitao developmentandinternalvalidationofriskstratificationtoolforlymphnodemetastasisinpt34laryngealsquamouscellcarcinomapatients